| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eabcb3659c4973d9aa298bba3554a447
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfb7abd574328512304673b6f3c73ea8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_140e62d6c6abda185cf1d3a693f21412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca32fd2a44fd326ffd027a75a57bd13f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2001-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_749b25b6dd56f1f9036c472d7b7c0ced
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_880168eb58ce1c2118fd86161533f429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e5c3f2a70f1276af35b63f794ef99f8 |
| publicationDate |
2002-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0238178-A1 |
| titleOfInvention |
Use of a compound antagonist of the esm-1 protein for producing a medicine for treating cancer |
| abstract |
The invention concerns the use of a compound antagonist of the ESM-1 protein for making a medicine for treating cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009053467-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009053467-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1565552-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1565552-A2 |
| priorityDate |
2000-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |